prikaz prve stranice dokumenta To Treat or Not To Treat—From Guidelines to Individualized Patient Management
  Preuzmi
PDF 142.73 KB
Stručni rad - Pregledni rad
To Treat or Not To Treat—From Guidelines to Individualized Patient Management
Seminars in Hematology, 50 (2013); 12-17. https://doi.org/10.1053/j.seminhematol.2013.03.004
Matzdorff, Alex; Neufeld, Ellis J.; Roganović, Jelena

Citirajte ovaj rad

Matzdorff, A., Neufeld, E. J. i Roganović, J. (2013). To Treat or Not To Treat—From Guidelines to Individualized Patient Management. Seminars in Hematology, 50., 12-17. doi: 10.1053/j.seminhematol.2013.03.004

Matzdorff, Alex, et al. "To Treat or Not To Treat—From Guidelines to Individualized Patient Management." Seminars in Hematology, vol. 50, 2013, str. 12-17. https://doi.org/10.1053/j.seminhematol.2013.03.004

Matzdorff, Alex, Ellis J. Neufeld i Jelena Roganović. "To Treat or Not To Treat—From Guidelines to Individualized Patient Management." Seminars in Hematology 50 (2013): 12-17. https://doi.org/10.1053/j.seminhematol.2013.03.004

Matzdorff, A., Neufeld, E. J. i Roganović, J. (2013) 'To Treat or Not To Treat—From Guidelines to Individualized Patient Management', Seminars in Hematology, 50, str. 12-17. doi: 10.1053/j.seminhematol.2013.03.004

Matzdorff A, Neufeld EJ, Roganović J. To Treat or Not To Treat—From Guidelines to Individualized Patient Management. Seminars in Hematology [Internet]. 2013. [pristupljeno 31.12.2024.];50:12-17. doi: 10.1053/j.seminhematol.2013.03.004

A. Matzdorff, E. J. Neufeld i J. Roganović, "To Treat or Not To Treat—From Guidelines to Individualized Patient Management", Seminars in Hematology, vol. 50, str. 12-17, 2013. [Online]. Dostupno na: https://urn.nsk.hr/urn:nbn:hr:184:013751. [Citirano: 31.12.2024.]

Za citiranje koristite ovu mrežnu adresu: https://urn.nsk.hr/urn:nbn:hr:184:013751
Prijavite se u repozitorij kako biste mogli spremiti objekt u svoju listu.
Podaci o radu
Naslov (engleski)To Treat or Not To Treat—From Guidelines to Individualized Patient Management
AutorAlex Matzdorff
AutorEllis J. Neufeld
AutorJelena Roganović
Autorova ustanovaSveučilište u Rijeci
Medicinski fakultet
(Katedra za pedijatriju)
Znanstveno / umjetničko
područje, polje i grana		BIOMEDICINA I ZDRAVSTVO
Kliničke medicinske znanosti
Interna medicina
Sažetak (engleski)
Immune thrombocytopenia (ITP) is a rare disorder. Evidence-based guidelines provide important information for hematologists, as well as diagnostic and therapeutic recommendations to other physicians with limited expertise in the field. However, guidelines in pediatric and adult ITP do not answer some imperative questions: which patient is at risk of severe bleeding and requires pharmacologic treatment? Who will recover spontaneously? Is splenectomy still an appropriate second-line treatment for all chronic or persistent ITP patients? This review summarizes the current approach to these important issues, the patients’ perspective, and how we can improve individual patient management
Ključne riječi (engleski)
Jezikengleski
Vrsta publikacijeStručni rad - Pregledni rad
Status objaveObjavljen
Vrsta recenzijeRecenziran - međunarodna recenzija
Verzija publikacijeObjavljena verzija rada (izdavačev PDF)
Naslov časopisaSeminars in Hematology
Brojčani podacivol. 50, str. 12-17
p-ISSN0037-1963
DOIhttps://doi.org/10.1053/j.seminhematol.2013.03.004
URN:NBNurn:nbn:hr:184:013751
Datum objave publikacije2013
URL dokumentahttp://dx.doi.org/10.1053/j.seminhematol.2013.03.004
Vrsta resursaTekst
Prava pristupaOtvoreni pristup
Uvjeti korištenjaIkona licence Imenovanje-Nekomercijalno-Bez prerada 4.0 međunarodna (CC BY-NC-ND 4.0)
Datum i vrijeme pohrane2018-05-30 08:47:08